{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Yuan S"],"funding":["Cancer Research UK","Wellcome Trust"],"pagination":["4491-4515"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12414872"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["292(17)"],"pubmed_abstract":["Ovarian cancer is the 3rd most common gynaecological malignancy worldwide, with a 5-year survival rate of < 30% in the presence of metastasis. Metastatic progression is characterised by extensive remodelling of the extracellular matrix, primarily mediated by secreted proteases, including members of the 'a disintegrin and metalloprotease with thrombospondin motif' (ADAMTS) family. In particular, ADAMTS5 has been reported to be upregulated in ovarian malignant tumours compared to borderline and benign lesions, suggesting it might play a role in metastatic progression. Furthermore, it has been suggested that Rab25, a small GTPase of the Ras family, might upregulate ADAMTS5 expression in ovarian cancer cells. Here we demonstrated that Rab25 promotes ADAMTS5 expression through the activation of"],"journal":["The FEBS journal"],"pubmed_title":["The protease ADAMTS5 controls ovarian cancer cell invasion, downstream of Rab25."],"pmcid":["PMC12414872"],"funding_grant_id":["C52879/A29144","WT093134AIA"],"pubmed_authors":["Bacchetti R","Nuti E","Yuan S","Santamaria S","Rainero E","Cuffaro D","Rossello A","Adams J"],"additional_accession":[]},"is_claimable":false,"name":"The protease ADAMTS5 controls ovarian cancer cell invasion, downstream of Rab25.","description":"Ovarian cancer is the 3rd most common gynaecological malignancy worldwide, with a 5-year survival rate of < 30% in the presence of metastasis. Metastatic progression is characterised by extensive remodelling of the extracellular matrix, primarily mediated by secreted proteases, including members of the 'a disintegrin and metalloprotease with thrombospondin motif' (ADAMTS) family. In particular, ADAMTS5 has been reported to be upregulated in ovarian malignant tumours compared to borderline and benign lesions, suggesting it might play a role in metastatic progression. Furthermore, it has been suggested that Rab25, a small GTPase of the Ras family, might upregulate ADAMTS5 expression in ovarian cancer cells. Here we demonstrated that Rab25 promotes ADAMTS5 expression through the activation of","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-02T02:27:17.39Z","creation":"2026-04-13T03:12:00.888Z"},"accession":"S-EPMC12414872","cross_references":{"pubmed":["40164572"],"doi":["10.1111/febs.70080"]}}